An Evaluation of the Effectiveness of Local Anesthetics Used During Intravenous Catheter Insertion

NCT ID: NCT02162680

Last Updated: 2014-08-15

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

99 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare how well different anesthetic, or numbing, solutions injected under the skin work in reducing the discomfort associated with placing a catheter in a vein. Two different medications, lidocaine and normal saline with benzyl alcohol, have been found to be effective in reducing discomfort when injected under the skin just prior to inserting the catheter. This study compares these two solutions, and will compare the discomfort that occurs both with and without using these solutions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

IV Insertion Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lidocaine

1% lidocaine intradermal injection

Group Type ACTIVE_COMPARATOR

1% lidocaine

Intervention Type DRUG

bacteriostatic normal saline (BNS)

bacteriostatic normal saline (BNS) injection

Group Type ACTIVE_COMPARATOR

bacteriostatic normal saline (BNS)

Intervention Type DRUG

no local anesthetic

usual care practice of no local anesthetic administration

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

1% lidocaine

Intervention Type DRUG

bacteriostatic normal saline (BNS)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients (aged 18 or older)
* admitted to a general medical or surgical unit at Durham Regional Hospital (DRH)
* have a physician's order for an IV
* are able to speak, read and understand English
* referred to the Vascular Access Specialty Team (VAST) at DRH for IV catheterization

Exclusion Criteria

* admission to the emergency room, pre-op unit, an outpatient unit, a psychiatric unit, an intensive care unit, a pre- or postnatal care unit, or labor and delivery units;
* history of a psychological disorder, as determined from the patient's chart;
* history of peripheral neuropathy, as determined by patient's chart;
* history of IV drug abuse, as determined from the patient's chart;
* decreased sensation in the arm or hands, as reported in the chart or by the patient;
* patient disorientation or confusion (i.e., unable to state person, place, time or unable to comprehend instructions for completing Visual Analog Scale);
* a known allergy to lidocaine or benzyl alcohol as determined from the patient's chart;
* veins that cannot be palpated and are difficult to visualize by VAST nurses;
* pregnancy;
* an order for the emergency insertion of an IV by the patient's doctor or assigned nurse;
* an IV insertion that requires the use of a catheter gauged 18 or larger
* severe vision impairment, as determined by the patient's inability to read the Visual Analogue Scale
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julia Aucoin, DNS, RN

Role: PRINCIPAL_INVESTIGATOR

Duke Health

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00015861

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Reducing Pain of Lidocaine Injection
NCT02288364 COMPLETED PHASE4
Intralipid® 20% for Reversal of Local Anesthetics
NCT03968822 ACTIVE_NOT_RECRUITING PHASE4